Contrast enhanced ultrasound imaging to support prostate cancer brachytherapy treatment and follow up after treatment.
Recruiting
- Conditions
- Prostate and cancer.
- Registration Number
- NL-OMON22373
- Lead Sponsor
- Academic Medical Centre Amsterdam, department of urology and department of radiotherapy
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
1. Histologically proven adenocarcinoma of the prostate;
2. Patients treated by external beam radiotherapy followed by a pulsed dose-rate (PDR) brachytherapy boost;
Exclusion Criteria
See inclusion criteria.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Can contrast enhanced ultrasound be used for the detection of prostate lesions suspicious for cancer that can be used for brachytherapy dose adjustment.
- Secondary Outcome Measures
Name Time Method Can contrast enhanced ultrasound of the prostate be used to follow up suspicious lesions of the prostate in prostate cancer patients after brachytherapy.